Advertisement

Persons > All
Find below all kinds of persons.Total search results: 9470 | Ordered by Country (descending)
1 2 3 ... 93 94 95
![]() ![]() |
![]() ![]() |
![]() ![]() |
![]() ![]() |
---|---|---|---|
Han, Jason (SGS 201701 Managing Director of SGS Vietnam) | Managing Director | SGS (Group) | Vietnam |
Abrams, Judith R. (Editas Medicine 201910– CMO before EMD Serono RnD Institute + CorMedix + Celgene + Novo Nordisk) | Chief Medical Officer (CMO) | Editas Medicine Inc. (Nasdaq: EDIT) | United States (USA) |
Adams, Tom (Pairwise 202308 CEO + Co-Founder before Monsanto 201708 VP Biotechnology) | Chief Executive Officer (CEO) | Pairwise (Group) | United States (USA) |
Afeyan, Noubar (Flagship Ventures 200603 managing partner + CEO) | Chief Executive Officer (CEO) | Flagship Pioneering | United States (USA) |
Agarwala, Sandip (Blue Owl Capital 202208 Managing Director at Owl Rock) | Managing Director | Blue Owl Capital (Group) | United States (USA) |
Agrawal, Sudhir (Idera 200612 CEO + CSO) | Chief Executive Officer (CEO) | Idera Pharmaceuticals Inc. (Nasdaq: IDRA) | United States (USA) |
Ahmed, Nadim (BMS 202109 EVP) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
Akkaraju, Srinivas (Srini) (Samsara BioCaptial 2016– Founder before Sofinnova Ventures + New Leaf Venture Partners) | Investment Manager | Samsara BioCapital (US) | United States (USA) |
Al-Wakeel, Yasir (Kronos Bio 202008– CFO + Head of CorpDev before Neon Therapeutics + Merrimack Pharma + Credit Suisse) | Chief Financial Officer (CFO) | Kronos Bio Inc. (Nasdaq: KRON) | United States (USA) |
Alexandre, Leslie (Life Science Washington 202108 CEO) | Chief Executive Officer (CEO) | Life Science Washington | United States (USA) |
Alles, Mark (Celgene 201306 EVP + Global Head Hematology + Oncology) | President/Director/Head Business Group/Unit/Division | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
Altshuler, David (Vertex 201510 EVP Global Research + CSO before Broad Institute 200510) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Vertex Pharmaceuticals (Group) | United States (USA) |
Amariglio, Roy (OrbiMed 201605– Principal before Bayer HealthCare) | Principal (venture capital) | OrbiMed (Group) | United States (USA) |
Anacleto, Joe (Bruker 201312 VP of Market Development before AB SCIEX + Life Technologies) | Business Development Manager / Strategy Manager | Bruker (Group) | United States (USA) |
Ancher-Jensen, Henrik (Agilent 201309– SVP + President of Agilent Order Fulfillment before Dako + Chr Hansen) | President/Director/Head Business Group/Unit/Division | Agilent (Group) | United States (USA) |
Anderson, Bonnie H. (PinkDx 202404 CEO + Co-Founder before Veracyte 201409 CEO + Co-Founder) | Chief Executive Officer (CEO) | PinkDx Inc. | United States (USA) |
Anderson, Daniel G. (MIT 201705 + CRISPR Therapeutics Scientific Founder + Advisory Board Member) | Researcher (university / research institute) | MIT (Massachusetts Institute of Technology) | United States (USA) |
Anderson, David (Ampersand 201905 General Partner) | General Partner (venture partner) | Ampersand (Group) | United States (USA) |
Anderson, Errik (Biomatics Capital 201811– Venture Partner + Alloy Therapeutics before Adimab + Compass Therapeutics) | Venture Partner | Biomatics Capital Partners (US) | United States (USA) |
Anderson, Mary L. (Xoma 200803– VP Business Developm before Merck-Serono) | Business Development Manager / Strategy Manager | Xoma (Group) | United States (USA) |
Anderson, N. Leigh (Plasma Proteome Institute 200808 + SCISCAPA Assay Technologies) | mass spectrometry (MS) | Plasma Proteome Institute (PPI) | United States (USA) |
Anderson, Timothy (Tim) (Blue Owl Capital 202501 at Blue Owl Healthcare Opps before Cowen Healthcare Investments) | Investment Manager | Blue Owl Capital (Group) | United States (USA) |
Andrews, Richard (Rick) (Azitra –202010–202105 CEO RETIRED 5/21) | Chief Executive Officer (CEO) | Azitra Inc. | United States (USA) |
Andrews, Ron A. (Ronnie) (Life Technologies 201202– President Medical Sciences before GE Healthcare + CEO of Clarient) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | United States (USA) |
Ang, Robert (Vor Biopharma 201908– CEO before Neon Tx + Bavarian Nordic + Cadence Pharma + Frazier Healthcare Ventures) | Chief Executive Officer (CEO) | Vor Biopharma Inc. (Nasdaq: VOR) | United States (USA) |
Anzalone, Christopher (Arrowhead Research 201503 CEO) | Chief Executive Officer (CEO) | Arrowhead (Group) | United States (USA) |
Apicerno, Ken (Thermo Fisher 201003 Investor Relations) | Public Relations Manager / Investor Relations Manager | Thermo Fisher (Group) | United States (USA) |
Apte, Arun (Premier Biosoft 201210 CEO) | Chief Executive Officer (CEO) | Premier Biosoft (Group) | United States (USA) |
Arbogast, Susanne (Roche 201308 Head Innovation + External Affairs at Roche Diagnostics) | Business Development Manager / Strategy Manager | Roche (Group) | United States (USA) |
Arciero, Michael (ERS Genomics 202009– VP IP + Commercial Development before USC Stevents Center for Innovation) | IP Manager | University of Southern California (USC) | United States (USA) |
Armen, Garo H. (Agenus 201402 CEO) | Chief Executive Officer (CEO) | Agenus (Group) | United States (USA) |
Armstrong, Robert (Rob) (Boston Pharmaceuticals 201511– CEO before Eli Lilly + Amgen | Chief Executive Officer (CEO) | BERTARELLI Group (family of Ernesto Bertarelli) | United States (USA) |
Arnold, Drew (Cartagenia 201203– VP Sales + BusDev North America before GenomeQuest/Gene-IT + Lion Bioscience) | Sales Manager / Marketing Manager | Agilent (Group) | United States (USA) |
Arnold, Lauren (MacDougall Biomedical Communications 201801) | Public Relations Manager / Investor Relations Manager | MacDougall Advisors Inc. | United States (USA) |
Arnot, Christopher (Merck (DE) 202209 Director BusDev + Licensing Gene Editing + Novel Modalities at Sigma-Aldrich) | Business Development Manager / Strategy Manager | Merck (DE) (Group) | United States (USA) |
Artuso, Anthony (Merck (DE) 201310 VP Strategy + Business Development at EMD Millipore) | Chief Executive Officer (CEO) | Merck (DE) (Group) | United States (USA) |
Asadi, Narges Bani (Bina Technologies 201412 CEO + Founder) | Chief Executive Officer (CEO) | Roche (Group) | United States (USA) |
Asali, Omar (Ranpak 202110 CEO) | Chief Executive Officer (CEO) | Ranpak (US) | United States (USA) |
Asanuma, Sakae (Otsuka 201705 President of Taiho Ventures) | President/Director/Head Business Group/Unit/Division | Otsuka (Group) | United States (USA) |
Ascione, Roberto (Eversana 202410 President Health Innovation before Healthware Group) | President/Director/Head Business Group/Unit/Division | Eversana (Group) | United States (USA) |
Ashton, Paul (Inflammasome Therapeutics 201909 CEO) | Chief Executive Officer (CEO) | Inflammasome Therapeutics (US) | United States (USA) |
Asokan, Aravind (Univ of North Carolina at Chapel Hill 201704 + StrideBio Co-Founder) | Researcher (university / research institute) | University of North Carolina | United States (USA) |
Aspinall, Mara G. (Roche 201109– President Ventana Medical before On-Q-ity founder + CEO before Genzyme) | President/Director/Head Business Group/Unit/Division | LabCorp (Group) | United States (USA) |
Audoly, Laurent (Parthenon Therapeutics 201909– CEO + Co-Founder before Kymera Therapeutics + Pierre Fabre + Pieris) | Chief Executive Officer (CEO) | Parthenon Therapeutics (US) | United States (USA) |
Autret, Arnaud (Illumina 202205– Head of European Operations at Illumina Ventures before M Ventures) | Principal (venture capital) | Illumina (Group) | United States (USA) |
Avery, Michelle (Tome Biosciences 202312 VP Corporate Affairs formerly MacDougall Biomedical Communications 201504) | Public Relations Manager / Investor Relations Manager | MacDougall Advisors Inc. | United States (USA) |
Axon, Steven (Steve) (Glycomine 202207– CEO before Prothelia + Apellis Pharmaceuticals + Merck KGaA) | Chief Executive Officer (CEO) | Glycomine Inc. | United States (USA) |
Azam, Usman (Oz) (Tmunity Therapeutics 201612– CEO before Novartis + Novaccel + Aspreva + JnJ) | Chief Executive Officer (CEO) | Gilead Sciences (Group) | United States (USA) |
Aziz, Kabeer (Adjuvant Capital 202105) | Investment Manager | Adjuvant Capital LLC | United States (USA) |
Babbush, Ryan (Alphabet 202101 Head of Quantum Algorithms at Google Quantum AI) | n. a. | Alphabet (formerly Google) (Group) | United States (USA) |
Babe, Greg (Bayer Corp 200807– CEO before CEO Bayer MaterialScience) | Chief Executive Officer (CEO) | Bayer (Group) | United States (USA) |
Babiss, Lee E. (Gotham Therapeutics 201810 CEO before Roche+ PPD + Glaxo Wellcome) | Chief Executive Officer (CEO) | Gotham Therapeutics (Group) | United States (USA) |
Baier, Manfred (Roche –201112 RETIRES 12/11 as head of Roche Applied Science) | President/Director/Head Business Group/Unit/Division | Roche (Group) | United States (USA) |
Bailey, Dione (Ingenuity Systems 201303 Director of Marketing) | Sales Manager / Marketing Manager | Qiagen (Group) | United States (USA) |
Baker, Haven (Pairwise 202308 CBO + Co-Founder) | Chief Business Officer (CBO) | Pairwise (Group) | United States (USA) |
Ball, Kristine (Soteria Biotherapeutics 202105 CEO) | Chief Executive Officer (CEO) | Soteria Biotherapeutics Inc. | United States (USA) |
Ball, Lori (BioStorage 201308 COO) | Chief Operating Officer (COO) | BioStorage (Group) | United States (USA) |
Ballmer, Allison (Agilent 202101– SVP Strategy + Corporate Development joined 5/18 before Roche + Biocartis) | Business Development Manager / Strategy Manager | Agilent (Group) | United States (USA) |
Bancel, Stéphane (Moderna 2011– CEO before bioMérieux 201010 CEO + Eli Lilly) | Chief Executive Officer (CEO) | Moderna (Group) | United States (USA) |
Bando, Hiroto (Minaris Regenerative Medicine 2102409 CEO) | Chief Executive Officer (CEO) | Minaris Regenerative Medicine (Group) | United States (USA) |
Baracchini, Edgardo (Xencor 201802 CBO) | Chief Business Officer (CBO) | Xencor Inc. (Nasdaq: XNCR) | United States (USA) |
Baran, Michael (Pfizer 201912 Principal at Pfizer Ventures + Exec Director External Science + Innovation) | Principal (venture capital) | Pfizer (Group) | United States (USA) |
Baratta, Melissa (Affect PR 201505) | Public Relations Manager / Investor Relations Manager | Affect Inc. | United States (USA) |
Barbier, Ann (Translate Bio 201804 CMO before Agios Pharmaceuticals + Shire + Envivo + JnJ + Aventis) | Chief Medical Officer (CMO) | Sanofi (Group) [since May 2011] | United States (USA) |
Barbieri, Allen (Biosynthetic Technologies LLC 201407 CEO) | Chief Executive Officer (CEO) | Biosynthetic Technologies LLC (BT) | United States (USA) |
Barnes, Jonae R. (Poxel 201704 SVP IR + PR before Sepracor 200601 VP Investor Relations) | Public Relations Manager / Investor Relations Manager | Dainippon Sumitomo (Group) | United States (USA) |
Barrish, Joel C. (Jnana Therapeutics 202211 CSO + Co-Founder) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | Jnana Therapeutics Inc. | United States (USA) |
Basiji, David A. (Amnis Corp 201108 CEO + co-founder) | Chief Executive Officer (CEO) | Merck (DE) (Group) | United States (USA) |
Bastian, Helge (Thermo Fisher 201406 General Manager Synthetic Biology before Indivumed + Sigma-Aldrich + SGS + Qiagen) | Managing Director | Thermo Fisher (Group) | United States (USA) |
Bates, Kathy L. (Mayo Clinic 201912 Senior Director Lab Services + Partnership Developm + Numares Supersvisory Board) | President/Director/Head of Research Organisation/Unit | Mayo Clinic | United States (USA) |
Batra, Udit (Waters 202009– CEO before Merck Life Sciences + Merck Millipore + Novartis + JnJ + McKinsey) | Chief Executive Officer (CEO) | Waters (Group) | United States (USA) |
Bauler, James (Flag Therapeutics 201901 Director Corporate Development) | Business Development Manager / Strategy Manager | Flag Therapeutics (US) | United States (USA) |
Baumgartner, Tina (Accella Group 200806– Principal before Guava Technologies + SurroMed + GeneTrace Systems) | Consultant (economic/technology) | Accella Group | United States (USA) |
Baynes, Roy (Eikon Therapeutics 202401 EVP + CMO before Merck Research Laboratories + Gilead + Amgen) | Research & Development Manager | Eikon Therapeutics (US) | United States (USA) |
Bazemore, Robert (Epizyme 201811 CEO) | Chief Executive Officer (CEO) | Epizyme Inc. (Nasdaq: EPZM) | United States (USA) |
Beattie, Greg (Charles River 201803 Corp VP Global Biologics Testing Solutions) | President/Director/Head Business Group/Unit/Division | Charles River (Group) | United States (USA) |
Beatty, Brad (BioProcess360 Partners 202406– Founding Partner) | Managing Partner (investment firm) | BioProcess360 Partners (US) | United States (USA) |
Bechthold, Erika (UpNano 202204–1st US Employee before Harvard Office for Technology Development) | n. a. | UpNano GmbH | United States (USA) |
Beck, Matthew L. S. (Matt) (Hookipa 202210 Investor Relations before CureVac + Solebury Trout) | Public Relations Manager / Investor Relations Manager | Hookipa (Group) | United States (USA) |
Beck, Thomas R. (Tom) (Fidelity Biosciences 201406 Executive Partner before Dyax + UCB Pharma) | Partner (venture partner) | F-Prime (Group) | United States (USA) |
Becker, Chris (Protein Metrics 201209 CEO) | Chief Executive Officer (CEO) | Insightful Science (Group) | United States (USA) |
Beecher, Chris (IROA Technologies 201309 CSO) | Chief Scientific Officer (CSO) / Chief Development Officer (CDO) | IROA Technologies LLC | United States (USA) |
Behbahani, Ali (New Enterprise Associates 201504) | Investment Manager | New Enterprise Associates (NEA) | United States (USA) |
Behrendt, Ulrich (Roche Diagnostics 200706 also VBU Board Member Chairman 200706) | n. a. | Roche (Group) | United States (USA) |
Behrens, Jeff (Siamab Therapeutics 201710 CEO) | Chief Executive Officer (CEO) | Siamab Therapeutics Inc. | United States (USA) |
Beim, Piraye Yurttas (Celmatix 201910 CEO + Founder) | Chief Executive Officer (CEO) | Celmatix Inc. | United States (USA) |
Belani, Ravi (Alchemist Accelerator 201902 Managing Director) | Managing Director | Alchemist Accelerator (US) | United States (USA) |
Belaya, Julia (Plug and Play 201809 Director Health) | n. a. | Plug and Play (Group) | United States (USA) |
Bellemin, Jean-Marc (Gritsone Oncology 201801– CFO before Actelion + Guerbet) | Chief Financial Officer (CFO) | Gritstone Oncology Inc. | United States (USA) |
Beller, Maggie (Russo Partners 201808) | Public Relations Manager / Investor Relations Manager | Russo Partners LLC | United States (USA) |
Bence, Neil (BMS 202402 VP Head of Oncology Discovery) | Research & Development Manager | Bristol Myers Squibb (BMS) (Group) | United States (USA) |
Benesh, DeAnn (AOAC International 201807 President) | President/Director/Head Business Group/Unit/Division | AOAC International | United States (USA) |
Benioff, Marc (Salesforce 202012 CEO) | Chief Executive Officer (CEO) | Salesforce.com Inc. (NYSE: CRM) | United States (USA) |
Benjamin, Dennis (Seattle Genetics 201802 SVP Research) | Research & Development Manager | Pfizer (Group) | United States (USA) |
Benjamin, Laura (Oncologie Inc 201802 CEO) | Chief Executive Officer (CEO) | Oncologie Inc. (US/CN) | United States (USA) |
Beresford, Paul J. (Agilent 202304 VP + GM of CDx Division formerly at Biodesix before Roche + Ventana) | General Manager (management) | Agilent (Group) | United States (USA) |
Berger, Ken (Thermo Fisher 201201 SVP Specialty Diagnostics Business) | President/Director/Head Business Group/Unit/Division | Thermo Fisher (Group) | United States (USA) |
Bergo, Vladislav (Adeptrix 202101 CEO + Founder) | Chief Executive Officer (CEO) | Adeptrix Corporation | United States (USA) |
Berlin, Vivian (Harvard Univ 201305 Director Business Developmet at Office of Technology Development) | Business Development Manager / Strategy Manager | Harvard University | United States (USA) |
Bermingham, Nessan (Khosla Ventures 202206 Partner before Intellia Therapeutics 201411– CEO + Co-founder) | Chief Executive Officer (CEO) | Khosla Ventures | United States (USA) |


Advertisement

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to [email protected] and simply fill the subject line with the word »LSE Newsletter«
Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]
Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)
Advertisement

» top